– Opens for subscription today; closes on August 21.
– Aims to raise ₹451.3 crore, split between a fresh issue (₹175 crore) and an offer for sale (₹276.3 crore).
– Minimum retail investment: ₹14,950 at the upper price band of ₹319 per share.
– Founded over two decades ago; specializes in essential oils, aroma chemicals, mint derivatives, clove derivatives & synthetic/natural ingredients.
– Operates three plants and exports to major markets including the U.S., which accounts for over half of revenue.
– FY25 Revenue: ₹504 crore; EBITDA Margin: 17.6%; PAT Margin: 10.6%.
– Anand Rathi recommends “Subscribe – Long Term,” noting established market position but cautioning about customer concentration risks and premium valuations.
The Gem Aromatics IPO reflects India’s growing footprint in specialty chemicals and fragrances with significant export contributions showcasing global competitiveness. While its operational presence across strategic ingredient categories makes it a noteworthy prospect in its sector, risks such as dependency on key customers may influence investor sentiment alongside valuation concerns.
This IPO underscores the steady expansion in niche manufacturing sectors that bolster both India’s domestic sophistication and export performance while driving employment opportunities within local economies like Dahej or budaun contributing industrial hubs.Read More